Aarti Drugs Ltd 18 Jun 2024 12:00 AM
Aarti Drugs reports fire incident at one of its unit at Tarapur,
Aarti Drugs announced that on 17 June 2024, at around 2:30 pm IST, fire occurred at N-198 unit located at Tarapur, Maharashtra. Particular unit manufactures certain Active Pharmaceutical Ingredients (API) products for external customers. The fire was brought under control immediately, however production operation of the said unit has been temporarily disrupted. There is no loss of life or injuries reported. Adequate steps are being undertaken to restore the operation of the unit. The unit has adequate insurance coverage and intimation to Insurance Company has already been made. The Company projects no material impact on the financials and operations of business. Powered by Capital Market - Live News
Aarti Drugs Ltd 04 May 2024 12:00 AM
Aarti Drugs consolidated net profit declines 15.55% in the March 2024 quarter,
Net profit of Aarti Drugs declined 15.55% to Rs 47.37 crore in the quarter ended March 2024 as against Rs 56.09 crore during the previous quarter ended March 2023. Sales declined 16.49% to Rs 619.99 crore in the quarter ended March 2024 as against Rs 742.41 crore during the previous quarter ended March 2023.For the full year,net profit rose 3.07% to Rs 171.42 crore in the year ended March 2024 as against Rs 166.31 crore during the previous year ended March 2023. Sales declined 6.90% to Rs 2528.58 crore in the year ended March 2024 as against Rs 2716.05 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales619.99742.41 -16 2528.582716.05 -7 OPM %13.8412.60 -12.5211.25 - PBDT77.7685.78 -9 286.98274.50 5 PBT64.1873.28 -12 235.53224.18 5 NP47.3756.09 -16 171.42166.31 3 Powered by Capital Market - Live News
Aarti Drugs Ltd 03 May 2024 12:00 AM
Aarti Drugs standalone net profit declines 32.03% in the March 2024 quarter,
Net profit of Aarti Drugs declined 32.03% to Rs 36.14 crore in the quarter ended March 2024 as against Rs 53.17 crore during the previous quarter ended March 2023. Sales declined 19.66% to Rs 559.53 crore in the quarter ended March 2024 as against Rs 696.41 crore during the previous quarter ended March 2023.For the full year,net profit declined 7.15% to Rs 141.88 crore in the year ended March 2024 as against Rs 152.81 crore during the previous year ended March 2023. Sales declined 9.25% to Rs 2266.91 crore in the year ended March 2024 as against Rs 2497.97 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales559.53696.41 -20 2266.912497.97 -9 OPM %12.3412.71 -11.7411.31 - PBDT62.0881.10 -23 240.15252.10 -5 PBT49.7469.42 -28 192.48204.81 -6 NP36.1453.17 -32 141.88152.81 -7 Powered by Capital Market - Live News
Aarti Drugs Ltd 27 Apr 2024 12:00 AM
Aarti Drugs to table results,
Aarti Drugs will hold a meeting of the Board of Directors of the Company on 3 May 2024.Powered by Capital Market - Live News
Aarti Drugs Ltd 23 Apr 2024 12:00 AM
Pinnacle Life Science`s Formulations (Oncology) unit completes USFDA inspection,
Aarti Drugs announced that the United States Food and Drug Administration (US FDA) has inspected the Formulations (Oncology) manufacturing facility of its Subsidiary (Pinnacle Life Science) at Baddi, Himachal Pradesh from 16 to 22 of April 2024.On conclusion of the inspection, the company has received 5 inspectionalobservations in Form 483, where none of the observations are related to Data Integrity. The company will work closely with US FDA in resolving all points. Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now